Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing pet ownership and spending on pet health
3.2.1.2 Growing awareness of preventive pet healthcare
3.2.1.3 Advancements in vaccine technology
3.2.2 Industry pitfalls and challenges
3.2.2.1 High development cost of vaccines
3.2.2.2 Stringent regulatory requirement
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Vaccine Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Modified/attenuated live
5.3 Inactivated
5.4 Other vaccine types
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Feline respiratory diseases
6.3 Feline leukemia
6.4 Feline panleukopenia (feline distemper)
6.5 Feline rabies
6.6 Other disease types
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Injectables
7.3 Intranasal
Chapter 8 Market Estimates and Forecast, By Component, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Combined vaccine
8.3 Mono vaccine
Chapter 9 Market Estimates and Forecast, By Duration of Immunity, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 1 year
9.3 3 years
9.4 Other durations of immunity
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
Chapter 11 Company Profiles
11.1 Bioveta
11.2 Boehringer Ingelheim
11.3 Durvet
11.4 Elanco
11.5 Indian Immunologicals
11.6 INTAS Animal Health
11.7 Merck
11.8 Spectra
11.9 Virbac
11.10 Zoetis
